Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UntroD Capital is a Tokyo-based venture capital firm specializing in seed and early-stage investments in deep tech startups globally. The company focuses on supporting R&D-driven companies that address global and human challenges through innovative technologies. It has managed multiple funds with assets exceeding 30 billion yen and operates as a subsidiary of Euglena.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UntroD Capital.